NeuroCME

This activity is expired and is no longer available for CME credit.

LECTURECME

In Search of the Guiding Light: Revisiting the Use of Oral and High-efficacy Therapies in a Modern Era of Multiple Sclerosis Treatment

Author(s)/Faculty: Patricia K. Coyle, MD, FAAN; Bruce A. Cohen, MD; Edward J. Fox, MD, PhD, FAAN; Kottil W. Rammohan, MD
Release Date: 7/20/2016Expiration Date: 7/19/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Treatments for multiple sclerosis (MS) have changed drastically in the past two decades. There are now multiple disease-modifying treatments (DMTs) available for MS patients that can reduce relapse frequency and prolong time to disability. New oral agents offer convenient and efficacious alternatives to subcutaneous therapies. Many gaps in knowledge remain regarding the optimal use of DMTs and prevention and management of their potential adverse effects. Some MS patients who require aggressive high-efficacy therapies are not receiving them, causing suboptimal treatment. In this activity, leading neurologists will address the identified gaps in knowledge and treatment of MS and encourage neurologists to change their practice behaviors to improve their patients’ health.